Email updates

Keep up to date with the latest news and content from Diagnostic Pathology and BioMed Central.

Open Access Short report

High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression

Liv Jonsson*, Alexander Gaber, David Ulmert, Mathias Uhlén, Anders Bjartell and Karin Jirström

Diagnostic Pathology 2011, 6:91  doi:10.1186/1746-1596-6-91

Article Metrics

2662
Total accesses


4
BioMed Central citations

Article metric FAQ

Accesses  

  • Last 30 days: 185 accesses
  • Last 365 days: 1016 accesses
  • All time: 2662 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information

Cited by